Sale!

Cardiolipin Antibodies Panel IgG IgA IgM Test

Original price was: $188.Current price is: $100.

-47%

The Cardiolipin Antibodies Panel IgG IgA IgM Test is a comprehensive diagnostic tool that detects autoantibodies associated with antiphospholipid syndrome and thrombotic disorders. This test measures three specific immunoglobulin classes – IgG, IgA, and IgM – providing a complete assessment of autoimmune conditions that can cause blood clots, recurrent miscarriages, and stroke. At only $100 USD, this advanced screening helps identify underlying autoimmune factors contributing to unexplained thrombotic events and pregnancy complications. The test requires no special preparation and offers same-day results when samples are collected Monday through Saturday by 9 AM. Early detection through this panel enables timely intervention and management strategies for patients at risk of serious cardiovascular and obstetric complications.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

Cardiolipin Antibodies Panel IgG IgA IgM Test

Comprehensive Introduction to Cardiolipin Antibodies Testing

The Cardiolipin Antibodies Panel IgG IgA IgM Test represents a critical diagnostic advancement in autoimmune and thrombotic disorder evaluation. This comprehensive panel specifically detects autoantibodies directed against cardiolipin, a phospholipid component of cell membranes, particularly in platelets and endothelial cells. The presence of these antibodies is strongly associated with antiphospholipid syndrome (APS), a serious autoimmune condition characterized by abnormal blood clotting, recurrent pregnancy loss, and various thrombotic complications.

Understanding cardiolipin antibodies is essential because they interfere with normal blood coagulation processes, leading to increased risk of arterial and venous thrombosis. The test’s importance extends beyond simple detection – it provides crucial information for managing patients with unexplained thrombotic events, autoimmune diseases, and recurrent pregnancy complications. Early identification through this panel enables healthcare providers to implement appropriate anticoagulation therapy and preventive measures.

What the Test Measures and Detects

The Cardiolipin Antibodies Panel measures three distinct immunoglobulin classes:

  • IgG Cardiolipin Antibodies: The most clinically significant class, strongly associated with thrombotic events and pregnancy complications
  • IgM Cardiolipin Antibodies: Often present in infectious conditions but can contribute to thrombotic risk
  • IgA Cardiolipin Antibodies: Provides additional diagnostic information, particularly in patients with negative IgG and IgM results

This comprehensive approach detects autoimmune responses that target phospholipid-binding proteins, disrupting normal anticoagulant mechanisms and promoting thrombosis. The test utilizes advanced Enzyme Immunoassay methodology for precise quantification and reliable results.

Who Should Consider This Test

This test is recommended for individuals experiencing:

  • Unexplained venous or arterial thrombosis
  • Recurrent pregnancy loss or late-term fetal demise
  • Premature delivery due to placental insufficiency
  • Unexplained stroke in young patients
  • Autoimmune disease symptoms with thrombotic complications
  • Family history of antiphospholipid syndrome
  • Unexplained thrombocytopenia
  • Livedo reticularis or other skin manifestations

Significant Benefits of Cardiolipin Antibodies Testing

Undergoing the Cardiolipin Antibodies Panel offers multiple advantages:

  • Early Risk Identification: Detect autoimmune factors before serious thrombotic events occur
  • Pregnancy Management: Guide appropriate treatment for women with recurrent pregnancy loss
  • Treatment Guidance: Inform anticoagulation therapy decisions and duration
  • Comprehensive Assessment: Evaluate all three antibody classes for complete diagnostic picture
  • Same-Day Results: Rapid turnaround enables timely clinical decisions
  • No Special Preparation: Convenient testing without dietary restrictions or fasting requirements

Understanding Your Test Results

Test results are typically reported as negative, low positive, medium positive, or high positive for each antibody class. Interpretation requires clinical correlation:

  • Negative Results: No detectable cardiolipin antibodies; low probability of antiphospholipid syndrome
  • Low Positive: May require repeat testing and clinical evaluation
  • Medium to High Positive: Strongly suggestive of antiphospholipid syndrome, especially if persistent
  • IgG Dominance: Most clinically significant for thrombotic risk assessment

Positive results should be confirmed with repeat testing after 12 weeks to establish persistence, as required for formal antiphospholipid syndrome diagnosis. Your healthcare provider will interpret results in the context of your clinical presentation and may recommend additional testing.

Test Pricing and Availability

Price Type Amount (USD)
Discount Price $100
Regular Price $188

Convenient Testing Locations Across USA

GGC DNA maintains comprehensive testing facilities in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, Austin, Jacksonville, Fort Worth, Columbus, San Francisco, and many other cities. Our nationwide network ensures accessible testing with consistent quality standards.

Book Your Test Today

Take control of your health with comprehensive Cardiolipin Antibodies testing. Our experienced team provides professional sample collection and rapid same-day results when samples are submitted Monday through Saturday by 9 AM. No special preparation is required – simply schedule your appointment and visit our conveniently located facility.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your Cardiolipin Antibodies Panel IgG IgA IgM Test and receive professional guidance from our healthcare specialists.